Active ingredientDexmedetomidineCat. No. P-D074-001CAS 113775-47-6Family · Pharmaceutical analytical standards
Dexmedetomidine
An alpha-2 agonist sedative related to clonidine, approved in the United States in 1999 for short-term sedation in intensive care. Today it is also used in surgery, for acute agitation and in veterinary medicine for dogs and cats. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?The sedation it produces resembles natural sleep and does not depress breathing; for dogs there is a gel applied inside the mouth, approved in 2015, to ease fear of loud noises.
Go to the active ingredient →Active ingredientDexmedetomidineCat. No. P-D074-001CAS 113775-47-6
Active ingredientDexmedetomidine HydrochlorideCat. No. P-D074-002CAS 145108-58-3
Isotopically labelledDexmedetomidine-13C-d3 HClCat. No. P-D074-003
Isotopically labelledDexmedetomidine-d4 L-TartrateCat. No. P-D074-004
NitrosamineN-Nitroso DexmedetomidineCat. No. P-D074-005
ImpurityDexmedetomidine Impurity 1Cat. No. P-D074-006
ImpurityN1-Hydroxy DexmedetomidineCat. No. P-D074-007
ImpurityN3-Hydroxy DexmedetomidineCat. No. P-D074-008
ImpurityRezatomidineCat. No. P-D074-009CAS 847829-38-3No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.